LTRN
LTRN
NASDAQ · Biotechnology

Lantern Pharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$4.17
+0.10 (+2.46%)
As of Jun 30, 10:46 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +523.0% upside
Low Target $20.93
Average Target $25.98
High Target $39.39
Current Price $4.17
Current
$4.17
Target
$25.98
$20.93 $25.98 avg $39.39
Scenario Analysis
Bear Case
$20.93
401.9%
Low target
Base Case
$25.98
+523.0%
Avg target
Bull Case
$39.39
+844.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$5.74
-27.4% from high
52-Week Low
$1.11
+275.7% from low
Target vs 52W High
$25.98
+352.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%